Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Major Depression Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

5 recruiting trials for Major Depression. Eligibility criteria explained in plain English.

TrialFinderData lists 5 Major Depression clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Research is led by National Institute of Mental Health (NIMH) (1), Mark Niciu (1), Pontificia Universidad Catolica de Chile (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Electroconvulsive Therapy (ECT) (device, 1 trial), followed by Transcranial Magnetic Stimulation (TMS), Ketamine.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
5
Total Trials
5
Recruiting Now
0
Phase 3 Trials
5
Sponsors

Track Major Depression trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05669703

NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder

Background: Mood disorders, such as bipolar disorder, can have serious effects on a person s life. People with bipolar disorder are more likely to have heart disease and abuse...

Sponsor: National Institute of Mental Health (NIMH)Enrolling: 12601 location
RECRUITINGNCT04480918

University of Iowa Interventional Psychiatry Service Patient Registry

The purpose of this study is to examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD) and Obsessive-Compulsive Disorder (OCD). These...

Sponsor: Mark NiciuEnrolling: 10001 location
RECRUITINGNCT07380451

Modular Intervention for Depression Study

The goal of this psychotherapy clinical trial is to evaluate whether a algorithm-based personalized modular psychotherapy is more effective than usual individual psychotherapy in...

Sponsor: Pontificia Universidad Catolica de ChileEnrolling: 1505 locations
RECRUITINGNCT01980147

Skills for Wellness

Severe mental illness such as schizophrenia and mood disorders typically develops at a young age and can cause life-long disability. Currently available treatments cannot cure...

Sponsor: Nova Scotia Health AuthorityEnrolling: 3602 locations
RECRUITINGNCT06763081

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

The purpose of this study is to identify and validate a panel of genetic markers associated with selective serotonin reuptake inhibitors (SSRI)-induced behavioural activation in...

Sponsor: University of ManitobaEnrolling: 1602 locations

Frequently Asked Questions

There are currently 5 clinical trials for Major Depression, with 5 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Major Depression, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Major Depression, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.